Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
After finishing at $23.41 in the prior trading day, Privia Health Group Inc (NASDAQ: PRVA) closed at $24.32, up 3.89%. In other words, the price has increased by $3.89 from its previous closing price. On the day, 0.92 million shares were traded. PRVA stock price reached its highest trading level at $24.51 during the session, while it also had its lowest trading level at $23.385.
Ratios:
Our goal is to gain a better understanding of PRVA by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.78 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 27.32. For the most recent quarter (mrq), Quick Ratio is recorded 1.67 and its Current Ratio is at 1.67. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Needham on January 10, 2025, initiated with a Buy rating and assigned the stock a target price of $25.
On October 11, 2024, KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and target price of $23.KeyBanc Capital Markets initiated its Overweight rating on October 11, 2024, with a $23 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 13 ’25 when Mehrotra Parth sold 15,909 shares for $24.52 per share. The transaction valued at 390,089 led to the insider holds 407,234 shares of the business.
Mehrotra Parth sold 13,773 shares of PRVA for $344,187 on May 12 ’25. The Chief Executive Officer now owns 423,143 shares after completing the transaction at $24.99 per share. On May 12 ’25, another insider, Mountcastle David, who serves as the EVP & Chief Financial Officer of the company, sold 3,322 shares for $24.99 each. As a result, the insider received 83,017 and left with 172,909 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRVA now has a Market Capitalization of 2991397120 and an Enterprise Value of 2609917184. As of this moment, Privia’s Price-to-Earnings (P/E) ratio for their current fiscal year is 171.27, and their Forward P/E ratio for the next fiscal year is 65.04. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.89. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.46 while its Price-to-Book (P/B) ratio in mrq is 4.21. Its current Enterprise Value per Revenue stands at 1.278 whereas that against EBITDA is 69.995.
Stock Price History:
The Beta on a monthly basis for PRVA is 0.83, which has changed by 0.07188642 over the last 52 weeks, in comparison to a change of 0.14151978 over the same period for the S&P500. Over the past 52 weeks, PRVA has reached a high of $26.51, while it has fallen to a 52-week low of $18.77. The 50-Day Moving Average of the stock is 0.59%, while the 200-Day Moving Average is calculated to be 5.52%.
Shares Statistics:
The stock has traded on average 853.10K shares per day over the past 3-months and 1001310 shares per day over the last 10 days, according to various share statistics. A total of 122.87M shares are outstanding, with a floating share count of 109.19M. Insiders hold about 11.23% of the company’s shares, while institutions hold 93.79% stake in the company. Shares short for PRVA as of 1761868800 were 3395452 with a Short Ratio of 4.39, compared to 1759190400 on 3872515. Therefore, it implies a Short% of Shares Outstanding of 3395452 and a Short% of Float of 4.97.
Earnings Estimates
The dynamic stock of Privia Health Group Inc (PRVA) is currently being evaluated by a team of 8.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is $0.22, with high estimates of $0.28 and low estimates of $0.15.
Analysts are recommending an EPS of between $0.97 and $0.88 for the fiscal current year, implying an average EPS of $0.93. EPS for the following year is $1.03, with 10.0 analysts recommending between $1.16 and $0.77.
Revenue Estimates
13 analysts predict $514.94M in revenue for. The current quarter. It ranges from a high estimate of $552.1M to a low estimate of $490.24M. As of. The current estimate, Privia Health Group Inc’s year-ago sales were $460.9MFor the next quarter, 13 analysts are estimating revenue of $544.46M. There is a high estimate of $572.4M for the next quarter, whereas the lowest estimate is $522M.
A total of 14 analysts have provided revenue estimates for PRVA’s current fiscal year. The highest revenue estimate was $2.13B, while the lowest revenue estimate was $1.97B, resulting in an average revenue estimate of $2.08B. In the same quarter a year ago, actual revenue was $1.74BBased on 14 analysts’ estimates, the company’s revenue will be $2.28B in the next fiscal year. The high estimate is $2.38B and the low estimate is $2.14B.
